nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—CYP4A11—Rifampicin—leprosy	0.23	0.263	CbGbCtD
Cisplatin—ABCC5—Rifampicin—leprosy	0.176	0.201	CbGbCtD
Cisplatin—MPO—Dapsone—leprosy	0.119	0.136	CbGbCtD
Cisplatin—ABCC3—Rifampicin—leprosy	0.11	0.126	CbGbCtD
Cisplatin—PTGS2—Thalidomide—leprosy	0.0512	0.0587	CbGbCtD
Cisplatin—ABCC2—Rifampicin—leprosy	0.0502	0.0575	CbGbCtD
Cisplatin—PTGS2—Dapsone—leprosy	0.0409	0.0469	CbGbCtD
Cisplatin—CYP2B6—Rifampicin—leprosy	0.0319	0.0365	CbGbCtD
Cisplatin—CYP2C9—Thalidomide—leprosy	0.0174	0.0199	CbGbCtD
Cisplatin—CYP2C9—Rifampicin—leprosy	0.0169	0.0193	CbGbCtD
Cisplatin—ABCB1—Rifampicin—leprosy	0.0164	0.0187	CbGbCtD
Cisplatin—CYP2C9—Dapsone—leprosy	0.0139	0.0159	CbGbCtD
Cisplatin—Posterior reversible encephalopathy syndrome—Thalidomide—leprosy	0.00548	0.0862	CcSEcCtD
Cisplatin—Acute leukaemia—Thalidomide—leprosy	0.00315	0.0495	CcSEcCtD
Cisplatin—ATP7A—blood vessel—leprosy	0.00287	0.0607	CbGeAlD
Cisplatin—Skin necrosis—Thalidomide—leprosy	0.00257	0.0405	CcSEcCtD
Cisplatin—GSTM1—blood vessel—leprosy	0.00239	0.0505	CbGeAlD
Cisplatin—SLC31A1—Metal ion SLC transporters—SLC11A1—leprosy	0.00198	0.125	CbGpPWpGaD
Cisplatin—MT2A—eye—leprosy	0.00177	0.0373	CbGeAlD
Cisplatin—Skin exfoliation—Dapsone—leprosy	0.00168	0.0264	CcSEcCtD
Cisplatin—Venous thrombosis—Thalidomide—leprosy	0.00167	0.0262	CcSEcCtD
Cisplatin—MPO—IL23-mediated signaling events—IL23R—leprosy	0.00163	0.103	CbGpPWpGaD
Cisplatin—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00155	0.0243	CcSEcCtD
Cisplatin—MPO—blood vessel—leprosy	0.00154	0.0326	CbGeAlD
Cisplatin—MT2A—skin of body—leprosy	0.00154	0.0325	CbGeAlD
Cisplatin—Febrile neutropenia—Thalidomide—leprosy	0.0015	0.0235	CcSEcCtD
Cisplatin—PTGS2—hindlimb—leprosy	0.00146	0.0309	CbGeAlD
Cisplatin—Serum creatinine increased—Thalidomide—leprosy	0.00146	0.023	CcSEcCtD
Cisplatin—ABCC6—eye—leprosy	0.0014	0.0296	CbGeAlD
Cisplatin—PTGS2—appendage—leprosy	0.00126	0.0265	CbGeAlD
Cisplatin—MT1A—testis—leprosy	0.00116	0.0246	CbGeAlD
Cisplatin—SLC31A2—tendon—leprosy	0.00115	0.0243	CbGeAlD
Cisplatin—Nasopharyngitis—Dapsone—leprosy	0.00114	0.0179	CcSEcCtD
Cisplatin—GSTM1—skin of body—leprosy	0.00111	0.0234	CbGeAlD
Cisplatin—Pancreatitis—Dapsone—leprosy	0.00108	0.017	CcSEcCtD
Cisplatin—PTGS2—skin epidermis—leprosy	0.00104	0.0221	CbGeAlD
Cisplatin—ATP7B—testis—leprosy	0.00104	0.022	CbGeAlD
Cisplatin—ATP7B—nervous system—leprosy	0.00102	0.0216	CbGeAlD
Cisplatin—ATP7A—tendon—leprosy	0.00101	0.0214	CbGeAlD
Cisplatin—Cellulitis—Thalidomide—leprosy	0.000989	0.0156	CcSEcCtD
Cisplatin—Hyperuricaemia—Thalidomide—leprosy	0.00097	0.0152	CcSEcCtD
Cisplatin—MT2A—testis—leprosy	0.000968	0.0205	CbGeAlD
Cisplatin—Neuropathy peripheral—Dapsone—leprosy	0.000964	0.0152	CcSEcCtD
Cisplatin—SLC31A2—testis—leprosy	0.000951	0.0201	CbGeAlD
Cisplatin—MT2A—nervous system—leprosy	0.00095	0.0201	CbGeAlD
Cisplatin—Hearing impaired—Thalidomide—leprosy	0.000945	0.0149	CcSEcCtD
Cisplatin—SLC31A2—nervous system—leprosy	0.000934	0.0197	CbGeAlD
Cisplatin—GSTT1—nervous system—leprosy	0.00093	0.0196	CbGeAlD
Cisplatin—Blood uric acid increased—Thalidomide—leprosy	0.000916	0.0144	CcSEcCtD
Cisplatin—Hepatocellular injury—Thalidomide—leprosy	0.0009	0.0141	CcSEcCtD
Cisplatin—NQO1—eye—leprosy	0.000892	0.0188	CbGeAlD
Cisplatin—SOD1—tendon—leprosy	0.000886	0.0187	CbGeAlD
Cisplatin—Hyperkalaemia—Thalidomide—leprosy	0.000884	0.0139	CcSEcCtD
Cisplatin—SLC31A1—tendon—leprosy	0.000863	0.0182	CbGeAlD
Cisplatin—Skin exfoliation—Thalidomide—leprosy	0.000859	0.0135	CcSEcCtD
Cisplatin—Neuropathy—Thalidomide—leprosy	0.000845	0.0133	CcSEcCtD
Cisplatin—ATP7A—testis—leprosy	0.000838	0.0177	CbGeAlD
Cisplatin—Tinnitus—Dapsone—leprosy	0.000823	0.0129	CcSEcCtD
Cisplatin—GSTP1—eye—leprosy	0.000797	0.0168	CbGeAlD
Cisplatin—NQO1—skin of body—leprosy	0.000776	0.0164	CbGeAlD
Cisplatin—Erythema—Dapsone—leprosy	0.000768	0.0121	CcSEcCtD
Cisplatin—SOD1—testis—leprosy	0.000734	0.0155	CbGeAlD
Cisplatin—Deafness—Thalidomide—leprosy	0.00073	0.0115	CcSEcCtD
Cisplatin—Vision blurred—Dapsone—leprosy	0.000724	0.0114	CcSEcCtD
Cisplatin—Cardiac failure congestive—Thalidomide—leprosy	0.00072	0.0113	CcSEcCtD
Cisplatin—SLC31A1—testis—leprosy	0.000715	0.0151	CbGeAlD
Cisplatin—MPO—skin of body—leprosy	0.000713	0.0151	CbGeAlD
Cisplatin—Renal failure acute—Thalidomide—leprosy	0.000707	0.0111	CcSEcCtD
Cisplatin—SLC31A1—nervous system—leprosy	0.000702	0.0148	CbGeAlD
Cisplatin—PTGS2—blood vessel—leprosy	0.000699	0.0148	CbGeAlD
Cisplatin—GSTM1—testis—leprosy	0.000698	0.0147	CbGeAlD
Cisplatin—Amnesia—Thalidomide—leprosy	0.000695	0.0109	CcSEcCtD
Cisplatin—GSTP1—skin of body—leprosy	0.000693	0.0147	CbGeAlD
Cisplatin—GSTM1—nervous system—leprosy	0.000685	0.0145	CbGeAlD
Cisplatin—SLC31A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000668	0.0421	CbGpPWpGaD
Cisplatin—Cerebrovascular accident—Thalidomide—leprosy	0.000666	0.0105	CcSEcCtD
Cisplatin—Hyponatraemia—Thalidomide—leprosy	0.000656	0.0103	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000653	0.0103	CcSEcCtD
Cisplatin—ABCC5—tendon—leprosy	0.000631	0.0133	CbGeAlD
Cisplatin—Face oedema—Thalidomide—leprosy	0.00063	0.00991	CcSEcCtD
Cisplatin—Tachycardia—Dapsone—leprosy	0.000612	0.00962	CcSEcCtD
Cisplatin—Blood creatinine increased—Thalidomide—leprosy	0.000612	0.00962	CcSEcCtD
Cisplatin—Dehydration—Thalidomide—leprosy	0.000607	0.00955	CcSEcCtD
Cisplatin—Orthostatic hypotension—Thalidomide—leprosy	0.000596	0.00938	CcSEcCtD
Cisplatin—Hypokalaemia—Thalidomide—leprosy	0.000594	0.00934	CcSEcCtD
Cisplatin—NQO1—tendon—leprosy	0.000591	0.0125	CbGeAlD
Cisplatin—Breast disorder—Thalidomide—leprosy	0.00059	0.00928	CcSEcCtD
Cisplatin—Cramp muscle—Thalidomide—leprosy	0.000588	0.00925	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000588	0.00925	CcSEcCtD
Cisplatin—Pancreatitis—Thalidomide—leprosy	0.000553	0.0087	CcSEcCtD
Cisplatin—Pancytopenia—Thalidomide—leprosy	0.000536	0.00843	CcSEcCtD
Cisplatin—GSTP1—tendon—leprosy	0.000528	0.0112	CbGeAlD
Cisplatin—ABCC5—testis—leprosy	0.000523	0.011	CbGeAlD
Cisplatin—Acute coronary syndrome—Thalidomide—leprosy	0.000496	0.0078	CcSEcCtD
Cisplatin—Body temperature increased—Dapsone—leprosy	0.000496	0.00779	CcSEcCtD
Cisplatin—Renal failure—Thalidomide—leprosy	0.000495	0.00778	CcSEcCtD
Cisplatin—Neuropathy peripheral—Thalidomide—leprosy	0.000493	0.00776	CcSEcCtD
Cisplatin—Myocardial infarction—Thalidomide—leprosy	0.000493	0.00776	CcSEcCtD
Cisplatin—Stomatitis—Thalidomide—leprosy	0.000491	0.00771	CcSEcCtD
Cisplatin—Conjunctivitis—Thalidomide—leprosy	0.000489	0.00769	CcSEcCtD
Cisplatin—NQO1—testis—leprosy	0.000489	0.0103	CbGeAlD
Cisplatin—NQO1—nervous system—leprosy	0.00048	0.0101	CbGeAlD
Cisplatin—MT2A—AP-1 transcription factor network—IL10—leprosy	0.000475	0.03	CbGpPWpGaD
Cisplatin—Bradycardia—Thalidomide—leprosy	0.00046	0.00723	CcSEcCtD
Cisplatin—MPO—testis—leprosy	0.00045	0.0095	CbGeAlD
Cisplatin—Urinary tract disorder—Thalidomide—leprosy	0.000446	0.00702	CcSEcCtD
Cisplatin—Urethral disorder—Thalidomide—leprosy	0.000443	0.00696	CcSEcCtD
Cisplatin—MPO—nervous system—leprosy	0.000441	0.00933	CbGeAlD
Cisplatin—ABCC3—testis—leprosy	0.000439	0.00928	CbGeAlD
Cisplatin—GSTP1—testis—leprosy	0.000437	0.00924	CbGeAlD
Cisplatin—Visual impairment—Thalidomide—leprosy	0.000435	0.00685	CcSEcCtD
Cisplatin—ABCB1—blood vessel—leprosy	0.000432	0.00913	CbGeAlD
Cisplatin—ABCC3—nervous system—leprosy	0.000431	0.0091	CbGeAlD
Cisplatin—GSTP1—nervous system—leprosy	0.000429	0.00906	CbGeAlD
Cisplatin—ABCC2—tendon—leprosy	0.000424	0.00895	CbGeAlD
Cisplatin—Eye disorder—Thalidomide—leprosy	0.000422	0.00664	CcSEcCtD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—RIPK2—leprosy	0.000421	0.0266	CbGpPWpGaD
Cisplatin—Tinnitus—Thalidomide—leprosy	0.000421	0.00662	CcSEcCtD
Cisplatin—BCHE—skin of body—leprosy	0.00042	0.00887	CbGeAlD
Cisplatin—Cardiac disorder—Thalidomide—leprosy	0.000419	0.00659	CcSEcCtD
Cisplatin—Immune system disorder—Thalidomide—leprosy	0.000408	0.00642	CcSEcCtD
Cisplatin—Mediastinal disorder—Thalidomide—leprosy	0.000407	0.0064	CcSEcCtD
Cisplatin—Arrhythmia—Thalidomide—leprosy	0.000404	0.00635	CcSEcCtD
Cisplatin—Alopecia—Thalidomide—leprosy	0.000399	0.00628	CcSEcCtD
Cisplatin—Vomiting—Dapsone—leprosy	0.000399	0.00627	CcSEcCtD
Cisplatin—Malnutrition—Thalidomide—leprosy	0.000393	0.00618	CcSEcCtD
Cisplatin—Flatulence—Thalidomide—leprosy	0.000388	0.00609	CcSEcCtD
Cisplatin—MT2A—Interferon gamma signaling—HLA-DRB1—leprosy	0.000387	0.0244	CbGpPWpGaD
Cisplatin—Muscle spasms—Thalidomide—leprosy	0.000378	0.00595	CcSEcCtD
Cisplatin—CYP2B6—skin of body—leprosy	0.000374	0.00791	CbGeAlD
Cisplatin—Nausea—Dapsone—leprosy	0.000372	0.00586	CcSEcCtD
Cisplatin—Vision blurred—Thalidomide—leprosy	0.000371	0.00583	CcSEcCtD
Cisplatin—Tremor—Thalidomide—leprosy	0.000368	0.00579	CcSEcCtD
Cisplatin—Ill-defined disorder—Thalidomide—leprosy	0.000365	0.00574	CcSEcCtD
Cisplatin—Anaemia—Thalidomide—leprosy	0.000363	0.00572	CcSEcCtD
Cisplatin—Malaise—Thalidomide—leprosy	0.000355	0.00558	CcSEcCtD
Cisplatin—Leukopenia—Thalidomide—leprosy	0.000352	0.00554	CcSEcCtD
Cisplatin—ABCC2—testis—leprosy	0.000351	0.00741	CbGeAlD
Cisplatin—Convulsion—Thalidomide—leprosy	0.000341	0.00536	CcSEcCtD
Cisplatin—Myalgia—Thalidomide—leprosy	0.000335	0.00526	CcSEcCtD
Cisplatin—Anxiety—Thalidomide—leprosy	0.000334	0.00525	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000333	0.00523	CcSEcCtD
Cisplatin—Discomfort—Thalidomide—leprosy	0.000331	0.0052	CcSEcCtD
Cisplatin—PTGS2—skin of body—leprosy	0.000323	0.00684	CbGeAlD
Cisplatin—Oedema—Thalidomide—leprosy	0.000321	0.00505	CcSEcCtD
Cisplatin—Infection—Thalidomide—leprosy	0.000319	0.00501	CcSEcCtD
Cisplatin—Nervous system disorder—Thalidomide—leprosy	0.000315	0.00495	CcSEcCtD
Cisplatin—Thrombocytopenia—Thalidomide—leprosy	0.000314	0.00494	CcSEcCtD
Cisplatin—Tachycardia—Thalidomide—leprosy	0.000313	0.00493	CcSEcCtD
Cisplatin—Skin disorder—Thalidomide—leprosy	0.000312	0.0049	CcSEcCtD
Cisplatin—Hyperhidrosis—Thalidomide—leprosy	0.00031	0.00488	CcSEcCtD
Cisplatin—Anorexia—Thalidomide—leprosy	0.000306	0.00481	CcSEcCtD
Cisplatin—SLC31A1—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000303	0.0192	CbGpPWpGaD
Cisplatin—Hypotension—Thalidomide—leprosy	0.0003	0.00472	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Thalidomide—leprosy	0.000292	0.0046	CcSEcCtD
Cisplatin—Paraesthesia—Thalidomide—leprosy	0.000288	0.00453	CcSEcCtD
Cisplatin—Dyspnoea—Thalidomide—leprosy	0.000286	0.0045	CcSEcCtD
Cisplatin—MT2A—Interferon gamma signaling—IFNG—leprosy	0.000282	0.0178	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—IFNG—leprosy	0.000279	0.0176	CbGpPWpGaD
Cisplatin—Decreased appetite—Thalidomide—leprosy	0.000279	0.00439	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Thalidomide—leprosy	0.000277	0.00436	CcSEcCtD
Cisplatin—Pain—Thalidomide—leprosy	0.000274	0.00432	CcSEcCtD
Cisplatin—BCHE—testis—leprosy	0.000265	0.00559	CbGeAlD
Cisplatin—Feeling abnormal—Thalidomide—leprosy	0.000264	0.00416	CcSEcCtD
Cisplatin—MPO—IL23-mediated signaling events—IFNG—leprosy	0.00026	0.0164	CbGpPWpGaD
Cisplatin—BCHE—nervous system—leprosy	0.00026	0.00549	CbGeAlD
Cisplatin—ABCG2—testis—leprosy	0.000256	0.0054	CbGeAlD
Cisplatin—Body temperature increased—Thalidomide—leprosy	0.000254	0.00399	CcSEcCtD
Cisplatin—MPO—IL23-mediated signaling events—CD4—leprosy	0.000251	0.0158	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—IL2—leprosy	0.000248	0.0157	CbGpPWpGaD
Cisplatin—PTGS2—tendon—leprosy	0.000246	0.0052	CbGeAlD
Cisplatin—Hypersensitivity—Thalidomide—leprosy	0.000236	0.00372	CcSEcCtD
Cisplatin—CYP2B6—testis—leprosy	0.000236	0.00499	CbGeAlD
Cisplatin—CYP2B6—nervous system—leprosy	0.000232	0.00489	CbGeAlD
Cisplatin—MPO—IL23-mediated signaling events—IL2—leprosy	0.000231	0.0146	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—IFNG—leprosy	0.00023	0.0145	CbGpPWpGaD
Cisplatin—Asthenia—Thalidomide—leprosy	0.00023	0.00362	CcSEcCtD
Cisplatin—Diarrhoea—Thalidomide—leprosy	0.00022	0.00345	CcSEcCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.000213	0.0134	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—RIPK2—leprosy	0.000204	0.0129	CbGpPWpGaD
Cisplatin—Vomiting—Thalidomide—leprosy	0.000204	0.00321	CcSEcCtD
Cisplatin—Rash—Thalidomide—leprosy	0.000202	0.00318	CcSEcCtD
Cisplatin—Dermatitis—Thalidomide—leprosy	0.000202	0.00318	CcSEcCtD
Cisplatin—MPO—Vitamin B12 Metabolism—IFNG—leprosy	0.000201	0.0127	CbGpPWpGaD
Cisplatin—PTGS2—nervous system—leprosy	0.0002	0.00423	CbGeAlD
Cisplatin—Nausea—Thalidomide—leprosy	0.000191	0.003	CcSEcCtD
Cisplatin—ATP7B—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000189	0.0119	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.000189	0.0119	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-DRB1—leprosy	0.000189	0.0119	CbGpPWpGaD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TNF—leprosy	0.000189	0.0119	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IFNG—leprosy	0.000187	0.0118	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—NOD2—leprosy	0.000185	0.0117	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—leprosy	0.000174	0.011	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—TNF—leprosy	0.000168	0.0106	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IL2—leprosy	0.000167	0.0105	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IFNG—leprosy	0.000164	0.0103	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000161	0.0102	CbGpPWpGaD
Cisplatin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000154	0.00974	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000154	0.00973	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000154	0.00973	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—CD4—leprosy	0.000153	0.00967	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—TNF—leprosy	0.000149	0.00941	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—IFNG—leprosy	0.000149	0.0094	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IL2—leprosy	0.000145	0.00917	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—IFNG—leprosy	0.000138	0.00871	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	0.000138	0.00869	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—TNF—leprosy	0.000138	0.00869	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—CD4—leprosy	0.00013	0.00822	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—TNF—leprosy	0.00013	0.00821	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—IFNG—leprosy	0.00013	0.0082	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000126	0.00796	CbGpPWpGaD
Cisplatin—ABCB1—testis—leprosy	0.000126	0.00267	CbGeAlD
Cisplatin—ABCB1—nervous system—leprosy	0.000124	0.00262	CbGeAlD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—leprosy	0.000123	0.00776	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—TNF—leprosy	0.000121	0.00766	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—IFNG—leprosy	0.000114	0.00717	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.000113	0.00712	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—TNF—leprosy	0.000106	0.00668	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CYLD—leprosy	0.000104	0.00654	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—leprosy	0.000103	0.00648	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—TNF—leprosy	9.64e-05	0.00608	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—SDHD—leprosy	9.61e-05	0.00606	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—TNF—leprosy	9.31e-05	0.00588	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IFNG—leprosy	9.21e-05	0.00582	CbGpPWpGaD
Cisplatin—MT2A—Immune System—PARK2—leprosy	9.16e-05	0.00578	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—leprosy	9.12e-05	0.00575	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—TNF—leprosy	8.41e-05	0.00531	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL2—leprosy	8.19e-05	0.00517	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—TNF—leprosy	7.35e-05	0.00464	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—SLC11A1—leprosy	7.08e-05	0.00447	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—leprosy	7.01e-05	0.00442	CbGpPWpGaD
Cisplatin—MT2A—Immune System—TLR2—leprosy	6.68e-05	0.00421	CbGpPWpGaD
Cisplatin—MT2A—Immune System—RIPK2—leprosy	6.68e-05	0.00421	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	6.63e-05	0.00419	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—IL2—leprosy	6.33e-05	0.004	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—SDHD—leprosy	6.19e-05	0.00391	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NOD2—leprosy	6.05e-05	0.00382	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	5.9e-05	0.00372	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL10—leprosy	5.55e-05	0.0035	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CD40LG—leprosy	5.55e-05	0.0035	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—SDHD—leprosy	5.26e-05	0.00332	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC11A1—leprosy	5.22e-05	0.00329	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—SDHD—leprosy	5.13e-05	0.00324	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD40LG—leprosy	5.12e-05	0.00323	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD8A—leprosy	5.06e-05	0.00319	CbGpPWpGaD
Cisplatin—XDH—Metabolism—SDHD—leprosy	4.6e-05	0.0029	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—TNF—leprosy	4.59e-05	0.0029	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	4.47e-05	0.00282	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—SDHD—leprosy	4.41e-05	0.00278	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—leprosy	4.29e-05	0.00271	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CD4—leprosy	4.23e-05	0.00267	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IFNG—leprosy	4.22e-05	0.00266	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC11A1—leprosy	4.14e-05	0.00261	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-DRB1—leprosy	4.12e-05	0.0026	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SLC11A1—leprosy	3.96e-05	0.0025	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—SDHD—leprosy	3.82e-05	0.00241	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC11A1—leprosy	3.6e-05	0.00227	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC11A1—leprosy	3.56e-05	0.00225	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IFNG—leprosy	3.34e-05	0.00211	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—IL2—leprosy	3.26e-05	0.00206	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IFNG—leprosy	3.26e-05	0.00206	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—SDHD—leprosy	3.25e-05	0.00205	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IFNG—leprosy	3.01e-05	0.0019	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL2—leprosy	2.97e-05	0.00187	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD4—leprosy	2.91e-05	0.00183	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL2—leprosy	2.9e-05	0.00183	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—TNF—leprosy	2.73e-05	0.00172	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL2—leprosy	2.67e-05	0.00169	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SDHD—leprosy	2.48e-05	0.00157	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SDHD—leprosy	2.24e-05	0.00142	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SDHD—leprosy	2.22e-05	0.0014	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TNF—leprosy	2.16e-05	0.00136	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TNF—leprosy	2.11e-05	0.00133	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.95e-05	0.00123	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SDHD—leprosy	1.71e-05	0.00108	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SDHD—leprosy	1.64e-05	0.00104	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SLC11A1—leprosy	1.53e-05	0.000969	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.47e-05	0.000928	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD4—leprosy	1.26e-05	0.000793	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SDHD—leprosy	1.21e-05	0.000765	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SDHD—leprosy	1.13e-05	0.000715	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.04e-05	0.000658	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—leprosy	4.87e-06	0.000307	CbGpPWpGaD
